Literature DB >> 19756244

Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm.

Timothy J Nelson1, Atta Behfar, Andre Terzic.   

Abstract

Beyond the palliative reach of today, medical therapies of tomorrow aim to treat the root cause of chronic degenerative diseases. Therapeutic repair encompasses the converging triad of rejuvenation, regeneration or replacement strategies that rely on self-healing processes, stem cell regeneration, and/or organ transplantation. Natural healing or rejuvenation exemplify inherent, baseline repair secured by tissue self-renewal and de novo cell biogenesis, particularly effective in organs with a high endogenous reparative capacity. Transplant medicine exploits the replacement strategy as a valuable option to recycle used parts and restore failing organ function by means of exogenous substitutes-it is, however, limited by donor shortage. Stem cell-based regeneration offers the next frontier of medical therapy through delivery of essentially unlimited pools of autologous or allogeneic, naive or modified, progenitor cells to achieve structural and functional repair. Translation into clinical applications requires the establishment of a regenerative medicine community of practice capable to bridge discovery with personalized treatment solutions. Indeed, this multidisciplinary specialized workforce will be capable to integrate the new science of embryology, immunology, and stem cell biology into bioinformatics and network medicine platforms, ensuring implementation of therapeutic repair strategies into individualized disease management algorithms.

Entities:  

Keywords:  regenerative medicine; therapeutic repair; tissue regeneration

Mesh:

Year:  2008        PMID: 19756244      PMCID: PMC2743025          DOI: 10.1111/j.1752-8062.2008.00039.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  22 in total

Review 1.  Myocyte renewal and ventricular remodelling.

Authors:  Piero Anversa; Bernardo Nadal-Ginard
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Prometheus's vulture and the stem-cell promise.

Authors:  Nadia Rosenthal
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

Review 3.  Adult stem cells for tissue repair - a new therapeutic concept?

Authors:  Martin Kørbling; Zeev Estrov
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

4.  A vision of individualized medicine in the context of global health.

Authors:  D A Cortese
Journal:  Clin Pharmacol Ther       Date:  2007-11       Impact factor: 6.875

5.  Prospects for stem cell-based therapy.

Authors:  George Q Daley; David T Scadden
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

Review 6.  Derive and conquer: sourcing and differentiating stem cells for therapeutic applications.

Authors:  Irina Klimanskaya; Nadia Rosenthal; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

Review 7.  Stem-cell therapy for cardiac disease.

Authors:  Vincent F M Segers; Richard T Lee
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

Review 8.  Advances in tissue and organ replacement.

Authors:  Anthony Atala
Journal:  Curr Stem Cell Res Ther       Date:  2008-01       Impact factor: 3.828

Review 9.  Human fetal mesenchymal stem cells.

Authors:  Keelin O'Donoghue; Jerry Chan
Journal:  Curr Stem Cell Res Ther       Date:  2006-09       Impact factor: 3.828

Review 10.  Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

Authors:  Giselle Chamberlain; James Fox; Brian Ashton; Jim Middleton
Journal:  Stem Cells       Date:  2007-07-26       Impact factor: 6.277

View more
  22 in total

1.  SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells.

Authors:  Anca Chiriac; Andre Terzic; Sungjo Park; Yasuhiro Ikeda; Randolph Faustino; Timothy J Nelson
Journal:  J Cardiovasc Transl Res       Date:  2010-09-15       Impact factor: 4.132

2.  Stem cell update: highlights from the 2010 Lugano Stem Cell Meeting.

Authors:  Silvana Bardelli; Giuseppe Astori; Daniel Sürder; Tiziano Tallone; Andre Terzic; Gianni Soldati; Tiziano Moccetti
Journal:  J Cardiovasc Transl Res       Date:  2010-10-30       Impact factor: 4.132

3.  ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.

Authors:  Jelena Zlatkovic-Lindor; D Kent Arrell; Satsuki Yamada; Timothy J Nelson; Andre Terzic
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

4.  Stem cell biobanks.

Authors:  Silvana Bardelli
Journal:  J Cardiovasc Transl Res       Date:  2009-10-16       Impact factor: 4.132

5.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

6.  Stem cell platforms for regenerative medicine.

Authors:  Timothy J Nelson; Atta Behfar; Satsuki Yamada; Almudena Martinez-Fernandez; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

7.  c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.

Authors:  Almudena Martinez-Fernandez; Timothy J Nelson; Yasuhiro Ikeda; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2010-02       Impact factor: 4.132

8.  The science and ethics of induced pluripotency: what will become of embryonic stem cells?

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

9.  Regenerative medicine: on the vanguard of health care.

Authors:  Andre Terzic; Clifford D Folmes; Almudena Martinez-Fernandez; Atta Behfar
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

10.  Stem Cell Factories - the Rebirth of Tissue Engineering and Regenerative Medicine.

Authors:  Beat M Frey; Steffen M Zeisberger; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.